| PERIOD ENDING | 28-Dec-08 | 30-Dec-07 | 31-Dec-06 | | Total Revenue | 6,767,650 | 7,439,460 | 8,033,354 | | Cost of Revenue | 4,012,727 | 4,164,083 | 4,438,236 | | | Gross Profit | 2,754,923 | 3,275,377 | 3,595,118 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,277,962 | 1,270,090 | 1,320,111 | | Non Recurring | 7,976,418 | 72,030 |
-
| | Others | 262,198 | 282,361 | 276,770 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (6,761,655) | 1,650,896 | 1,998,237 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 21,460 | 17,113 | 9,285 | | Earnings Before Interest And Taxes | (7,115,120) | 1,708,702 | 2,007,522 | | Interest Expense | 190,845 | 259,825 | 288,040 | | Income Before Tax | (7,305,965) | 1,448,877 | 1,719,482 | | Income Tax Expense | (658,400) | 473,300 | 558,700 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,647,565) | 975,577 | 1,160,782 | | | Non-recurring Events | | Discontinued Operations |
-
| 80,035 |
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (6,647,565) | 1,055,612 | 1,160,782 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($6,647,565) | $1,055,612 | $1,160,782 |
|
0.22% Nasdaq 
Income Statement
